biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Apparently, It Takes Gull to Be Me

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon Aug 25, 2023 8:03pm

66 Views

Post# 35606286

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Apparently, It Takes Gull to Be Me

Did I talk "badly" about DrDR or about her deal, that was done out of incompetence or malice.

The stock is at half a penny.

Do you think she did a good deal?

Now, if I praised her for it, you would be posting that I'm bankrupt, a liar, ugly and that I'm almost as stupid as you are.

No wait!

You already do that.

So I'll remain honest. It wasn't a good deal. Nor was the Chiesi deal.

jd

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments